Measurement of isoprostanes as markers of oxidative stress in neuronal tissue

Current Protocols in Toxicology

Volumn , Issue SUPPL. 39, 2009, Pages

  Milatovic, Dejan ^a   Aschner, Michael ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

F2 isoprostanes; Lipid peroxidation; Neuroprostanes; Oxidative damage

Indexed keywords

ARACHIDONIC ACID; BIOLOGICAL MARKER; FREE RADICAL; ISOPROSTANE DERIVATIVE;

CENTRAL NERVOUS SYSTEM DISEASE; GAS CHROMATOGRAPHY; IN VIVO STUDY; LIPID PEROXIDATION; MASS SPECTROMETRY; MEASUREMENT; NERVOUS TISSUE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; THIN LAYER CHROMATOGRAPHY;

EID: 61749089180     PISSN: 19349254     EISSN: 19349262     Source Type: Journal    
DOI: 10.1002/0471140856.tx1214s39     Document Type: Review

References (31)

1. Basu, S. 1998. Radioimmunoassay of 8-isoprostaglandin F2α: An index of oxidative injury via free radical-catalyzed lipid peroxidation. Prostaglandins Leukot. Essent. Fatty Acids 58:319-325.
2. Basu, S. 2008. F2-isoprostanes in human health and diseases: From molecular mechanisms to clinical implications. Antioxidants and Redox Signal. 10:1405-1434.
3. Ben-Ari, Y. and Cossart, R. 2000. Kainate, a double agent that generates seizures: Two decades of progress. Trends Neurosci. 23:580-587. Famm, S.S. and Morrow, J.D. 2003. The isoprostanes: Unique products of arachidonic acid oxidation-a review. Curr. Med. Chem. 10:1723-1740.
4. Fessel, J.P., Porter, N.A.,Moore, K.P., Sheller, J.R., and Roberts, L.J. 2nd. 2002. Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension. Proc. Natl. Acad. Sci. U.S.A. 99:16713-16718.
5. Floyd, R.A. 1997. Protective action of nitronebased free-radical traps against oxidative damage to the central nervous system. Adv. Pharmacol. 38:361-378.
6. Gao, L., Yin, H., Milne, G.L., Porter, N.A., and Morrow, J.D. 2006. Formation of F-ring isoprostane-like compounds (F3-isoprostanes) in vivo from eicosapentaenoic acid. J. Biol. Chem. 281:14092-14099.
7. Gupta, R.C., Milatovic, S., Dettbarn, W.-D., Aschner, M., and Milatovic, D. 2007. Neuronal oxidative injury and dendritic damage induced by carbofuran: Protection by memantine. Toxicol. Appl. Pharmacol. 219:97-105.
8. Gutteridge, J.M.C. and Halliwell, B. 1990. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem. Sci. 15:129-135.
9. Kadiiska, M.B., Gladen, B.C., Baird, D.D., Germolec, D., Graham, L.B., Parker, C.E., Nyska, A., Wachsman, J.T., Ames, B.N., Basu, S., Brot, N., Fitzgerald, G.A., Floyd, R.A., George, M., Heinecke, J.W., Hatch, G.E., Hensley, K., Lawson, J.A., Marnett, L.J., Morrow, J.D., Murray, D.M., Plastaras, J., Roberts, L.J. II, Rokach, J., Shigenaga, M.K., Sohal, R.S., Sun, J., Tice, R.R., Van Thiel, D.H., Wellner, D., Walter, P.B., Tomer, K.B., Mason, R.P., and Barrett, J.C. 2005. Biomarkers of oxidative stress study II: Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic. Biol.Med. 38:698-710. Lee, S.H. andBlair, I.A. 2001. OxidativeDNAdamage and cardiovascular disease. Trends Cardiovasc. Med. 11:148-155.
10. Liang, Y., Wei, P., Duke, R.W., Reaven, P.D., Harman, S.M., Cutler, R.G., and Heward, C.B. 2003. Quantification of 8-iso-prostaglandin- F(2a) and 2,3-dinor-8-iso-prostaglandin-F(2a) in human urine using liquid chromatographytandem mass spectrometry. Free Radic. Biol. Med. 34:409-418.
11. Milatovic, D., Zaja-Milatovic, S., Montine, K.S., Horner, P.J., andMontine, T.J. 2003. Pharmacologic suppression of neuronal oxidative damage and dendritic degeneration following direct activation of glial innate immunity in mouse cerebrum. J. Neurochem. 87:1518-1526.
12. Milatovic, D., Milatovic, S., Montine, K., Shie, F.S., and Montine, T.J. 2004. Neuronal oxidative damage and dendritic degeneration following activation of CD14-dependent innate immunity response in vivo. J. Neuroinflamm. 1:20.
13. Milatovic, D., VanRollins, M., Li, K., Montine, K.S., and Montine, T.J. 2005. Suppression of cerebral oxidative damage from excitotoxicity and innate immune response in vivo by α- or -α tocopherol. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 827:88-93.
14. Milatovic, D., Gupta, R.C., and Aschner, M. 2006. Anticholinesterase toxicity and oxidative stress. The Scientific World Journal 6:295-310.
15. Milatovic, D., Yin, Z., Gupta, R.C., Sydoryk, M., Albrecht, J., Aschner, J.L., and Aschner, M. 2007. Manganese induces oxidative impairment in cultured rat astrocytes. Toxicol. Science 98:198-205.
16. Montine, T.J, Milatovic, D., Gupta, R.C., Morrow, J.D., and Breyer, R. 2002. Neuronal oxidative damage from activated innate immunity in EP2 receptor-dependent. J. Neurochem. 83:463-470.
17. Montine, K.S., Quinn, J.F., Zhang, J., Fessel, J.P., Roberts, L.J., II, Morrow, J.D., and Montine, T.J. 2004. Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. Chem. Phys. Lipids 128:117-124.
18. Morrow, J.D. and Roberts, L.J. 1999. Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as ameasure of oxidant stress. Methods Enzymol. 300:3-12.
19. Morrow, J.D., Harris, T.M., and Roberts, L.J. II. 1990a. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: Analytical ramifications for measurement of eicosanoids. Anal. Biochem. 184:1-10.
20. Morrow, J.D., Hill, K.E., Burk, R.F., Nammour, T.M., Badr, K.F., and Roberts, L.J. 2nd. 1990b. A series of prostaglandin F2-like compounds are produced in vivo in humans by a noncyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. U.S.A. 87:9383-9387.
21. Morrow, J.D., Awad, J.A., Boss, H.J., Blair, I.A., and Roberts, L.J. II. 1992. Non-cyclooxygenase derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc. Natl. Acad. Sci. U.S.A. 89:10721-10725.
22. Morrow, J.D., Roberts, L.J., Daniel, V.C., Awad, J.A., Mirochnitchenko, O., Swift, L.L., and Burk, R.F. 1998. Comparison of formation of D2/ E2-isoprostanes and F2-isoprostanes in vitro and in vivo-effects of oxygen tension and glutathione. Arch. Biochem. Biophys. 353:160-171.
23. Pratico, D., Barry, O.P., Lawson, J.A., Adiyaman, M., Hwang, S.W., Khanapure, S.P., Iuliano, L., Rokach, J., and Fitzgerald, G.A. 1998. IPF2a-I: An index of lipid peroxidation in humans. Proc. Natl. Acad. Sci. U.S.A. 95:3449-3454.
24. Pratico, D., Rokach, J., Lawson, J., and FitzGerald, G.A. 2004. F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases. Chem. Phys. Lipids 128:165-171.
25. Reich, E.E., Markesbery, W.R., Roberts, L.J. II, Swift, J.D., Morrow, J.D., and Montine, J.T. 2001. Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease. Am. J. Pathol. 158:293-297.
26. Roberts, L.J. II, Montine, T.J., Markesbery, W.R., Tapper, A.R., Hardy, P., Chemtob, S., Dettbarn, W.D., and Morrow, J.D. 1998. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J. Biol. Chem. 273:13605-13612.
27. Salem, N., Kim, H.Y., and Lyergey, J.A. 1986. Docosahexaenoic acid: Membrane function and metabolism. In Health Effects of Polyunsaturated Acids in Seafoods (R.E. Martin, ed.) pp. 263-317. Academic Press, New York.
28. Simonian, N.A. and Coyle, J.T., 1996. Oxidative stress in neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 36:83-106.
29. Viquez, O.M., Valentine, H.L., Amarnath, K., Milatovic, D., and Valentine, W.M. 2008. Copper accumulation and lipid oxidation precede inflammation and myelin lesions in N,Ndiethyldithiocarbamate peripheral myelinopathy. Toxicol. Appl. Pharmacol. 229:77-85.
30. Wang, Z., Ciabattoni, G., Creminon, C., Lawson, J., Fitzgerald, G.A., Patrono, C., and Maclouf, J. 1995. Immunological characterization of urinary 8-epi-prostaglandin F2α excretion in man. J. Pharmacol. Exp. Ther. 275:94-100.
31. Zaja-Milatovic, S., Gupta, R.C., Aschner, M., Montine, T.J., and Milatovic, D. 2008. Pharmacologic suppression of oxidative damage and dendritic degeneration following kainic acid-induced excitotoxicity in mouse cerebrum. Neurotoxicol. 29:621-627.